Hodgkin's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Hodgkin's Disease, including details on causes, cancer, lymphoma, stages, symptoms.

Volume 7 (2010), Issue 9 (September)

1. 18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma.
   J Nucl Med, 51(9): 1337-43. [Abstract] [Full-text]
2. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.
   Blood, 116(9): 1469-78. [Abstract] [Full-text]
3. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.
   N Engl J Med, 363(7): 640-52. [Abstract] [Full-text]
4. 3D structural and functional characterization of the transition from Hodgkin to Reed-Sternberg cells.
   Ann Anat, 192(5): 302-8. [Abstract] [Full-text]
5. Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.
   J Clin Oncol, 28(27): 4199-206. [Abstract] [Full-text]
6. Application of MALDI imaging for the diagnosis of classical Hodgkin lymphoma.
   J Cancer Res Clin Oncol, 136(11): 1651-5. [Abstract] [Full-text]
7. Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).
   Blood, 116(12): 2026-32. [Abstract] [Full-text]
8. Application of MALDI imaging for the diagnosis of classical Hodgkin lymphoma.
   J Cancer Res Clin Oncol, 136(11): 1651-5. [Abstract] [Full-text]
9. Risk-based combined-modality therapy of pediatric Hodgkin's lymphoma: a retrospective study.
   Leuk Res, 34(11): 1447-52. [Abstract] [Full-text]
10. Oxaliplatin-based chemotherapy (dexamethasone, high-dose cytarabine, and oxaliplatin)±rituximab is an effective salvage regimen in patients with relapsed or refractory lymphoma.
    Cancer, 116(19): 4573-9. [Abstract] [Full-text]
11. Risk-based combined-modality therapy of pediatric Hodgkin's lymphoma: a retrospective study.
    Leuk Res, 34(11): 1447-52. [Abstract] [Full-text]
12. Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy.
    Br J Cancer, 103(7): 1081-4. [Abstract] [Full-text]

© 2004-2012 Hodgkin's Disease Research Today. All Rights Reserved.